Martine van Vugt
Genmab
Executive Vice President and Chief Strategy Officer

Paul Peter Tak
Candel Therapeutics
President & CEO

Carl Moons
UMC Utrecht | AI4Health
Professor

Conny Helder
Health Holland | FAST | Oncode Accelerator
Board member | Chair

Jakob van der Waarden
Ministry of Economic Affairs
Directeur Nationaal Groeifonds

Christoph Korpus
Byondis
CEO

Marc van Voorst tot Voorst
Forbion
Head of Public Affairs

Annemiek Verkamman
HollandBio
Managing Director

Tom van Helmond
Loyens & Loeff
Managing Partner NL

Carlijn Bouten
TU/e | HEALTH Institute
Professor | Scientific Director

Barend Bouma
NLO
Partner | European Patent Attorney

Nazma Ilahibaks
JAMA Therapeutics
CEO

Eline van Beest
Thuja Capital | TU Delft
Operating Partner | Professor

Tim Knotnerus
Agomab Therapeutics
CEO

Saco de Visser
FAST | Amsterdam UMC
Scientific Director | Professor

Carmen van Vilsteren
Angel Investor
Co-author of Lancet Paper Women's Health

Sebastian Asprella
EMA
Programme Lead, EU Competitiveness

Nathalie ter Wengel
Pfizer
Europe Worldwide BD Lead & Global Scouting Team Lead

Cara Antoine
EVP & Chief Technology, Innovation, AI & Portfolio Officer

Jorden Evegaars
jordenbastian
Founder | Fractional Operating Partner

Katleen De Stobbeleir
Vlerick Business School
Professor of Leadership